Pacific Biosciences Of California reported $68.18M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agilent A:US $ 1250M 13M
Bruker BRKR:US $ 485.2M 19.6M
Danaher DHR:US $ 5213M 365M
Fluidigm FLDM:US 48.29M 3.83M
General Electric GE:US $ 19273M 2407M
Genmark Diagnostics GNMK:US $ 52.17M 8.25M
Illumina ILMN:US $ 939M 39M
Luminex LMNX:US $ 97.23M 3.66M
Myriad Genetics MYGN:US $ 210.2M 9.6M
Nanostring Technologies NSTG:US $ 59.5M 2.01M
Oxford Immunotec Global OXFD:US 19.16M 3.49M
Pacific Biosciences Of California PACB:US $ 68.18M 46.52M
Perkinelmer PKI:US $ 895.98M 56.07M
Quidel QDEL:US $ 153.3M 2.15M
Thermo Fisher Scientific TMO:US $ 7110M 253M
Waters WAT:US $ 485.22M 47.95M